Related by context. All words. (Click for frequent words.) 78 Meets Primary Endpoint 77 Dasatinib 76 thalidomide Thalomid 76 Fondaparinux 75 Boceprevir 75 Gefitinib 75 adalimumab Humira 75 Prolongs Survival 75 GW# [003] 75 Pulmonary Arterial Hypertension 75 Melphalan 75 Antitumor Activity 75 Intravesical 75 Tezampanel 75 Dapagliflozin 75 Fluconazole 75 Aflibercept 74 Valsartan 74 Epratuzumab 74 JAK Inhibitor 74 Phase 2b Clinical Trial 74 Drug Candidate 74 Investigational Compound 74 Fulvestrant 74 Lacosamide 74 PKC# 74 sorafenib Nexavar 74 Pazopanib 74 Methylnaltrexone 74 Phase 2a Clinical Trial 74 Pertuzumab 74 Bevacizumab 74 Peginterferon 74 ACE Inhibitors 73 Tiotropium 73 Denufosol 73 Irinotecan 73 Oral Fingolimod 73 Tacrolimus 73 Epidermal Growth Factor Receptor 73 Mg Usa 73 Interferon Beta 73 Phase IIb Trial 73 Demonstrates Efficacy 73 Rivaroxaban 73 Romiplostim 73 Romidepsin 73 Montelukast 73 angiotensin receptor blocker ARB 73 Degarelix 73 Muraglitazar 73 Phase 2b Trial 73 Clinical Trial Results 73 antiplatelet agent 73 Maribavir 73 Oral Mucositis 73 Low Dose 73 ZOLINZA 73 Fluticasone 73 Candesartan 73 Pafuramidine 73 mapatumumab 73 Blinatumomab 72 Raltegravir 72 Tumor Necrosis Factor 72 Erlotinib 72 evaluating tivozanib 72 Daptomycin 72 Bortezomib 72 esomeprazole Nexium 72 PEGylated Fab fragment 72 investigational humanized monoclonal antibody 72 oral prodrug 72 Eculizumab 72 5 Fluorouracil 72 Golimumab 72 Telmisartan 72 Patients Treated With 72 INTEGRILIN R 72 Tyrosine Kinase Inhibitor 72 Bosutinib 72 Temsirolimus 72 Nilotinib 72 Aurora Kinase 72 Achieves Primary Endpoint 72 Omalizumab 72 Cholesterol Lowering Drug 72 Generic Version 72 Trandolapril 72 Cyclosporine 72 Celecoxib 72 etanercept Enbrel 72 Hypertensive Patients 72 Receptor Antagonists 72 Study Showed 72 Adjuvant Treatment 72 Losartan 72 Cethromycin 72 Zoloft sertraline 72 Silodosin 72 Diabetic Neuropathy 72 Zarnestra 72 Initiate Clinical Trial 72 Eltrombopag 72 Ambrisentan 72 candesartan cilexetil 72 Pemetrexed 72 Sapacitabine 72 proteasome inhibitor 72 Monoclonal Antibody 72 Bisphosphonate 72 Noxafil 72 TNF Tumor Necrosis Factor 72 Moxifloxacin 72 ADP receptor antagonist 72 Disease Progression 72 Investigational Treatment 72 Teriflunomide 72 selective modulator 72 Single Dose 72 Anti Tumor 72 Glatiramer Acetate 72 Itraconazole 72 Receptor Antagonist 72 aripiprazole Abilify 72 Angiotensin Converting Enzyme 72 Demonstrates Potent 72 Tyrima 71 Sitagliptin 71 rilonacept 71 mecamylamine 71 pan HDAC inhibitor 71 Bazedoxifene 71 erlotinib Tarceva ® 71 Overactive Bladder 71 Levetiracetam 71 corticosteroid dexamethasone 71 Complicated Skin 71 Monotherapy 71 Bicalutamide 71 Presents Preclinical Data 71 Nitazoxanide 71 Zorbtive TM 71 sulindac 71 Anthracycline 71 Kinase Inhibitor 71 cediranib 71 Zolinza 71 Vicriviroc 71 SIMCOR 71 MAGE A3 ASCI 71 Blood Pressure Drug 71 bortezomib Velcade 71 Lenalidomide 71 Carvedilol 71 Liposomal 71 Velcade bortezomib 71 Mipomersen 71 KRN# 71 Lubiprostone 71 tenofovir Viread 71 docetaxel Taxotere ® 71 Novel Mechanism 71 TLK# 71 Carfilzomib 71 factor Xa 71 Preclinical Study 71 Vidaza azacitidine 71 FDA Approvals 71 Fludara ® 71 Replacement Therapy 71 Fluorouracil 71 Safinamide 71 fluvastatin 71 Phase III Clinical Trial 71 Atypical Hemolytic Uremic Syndrome 71 Transdermal Patch 71 Myelodysplastic Syndrome MDS 71 Etanercept 71 Olmesartan 71 R lenalidomide 71 Factor VIIa 71 Pegylated Interferon 71 riociguat 71 Budesonide 71 Mg Uk 71 Traficet EN 71 dasatinib Sprycel 71 Hypercholesterolemia 71 angiotensin II receptor blocker 71 Dendritic Cells 71 Febuxostat 71 Panzem R 71 DFMO 71 YONDELIS 71 non peptidic protease 71 BRAF inhibitor 71 Calcitonin 71 AEGR 71 Capecitabine 71 Diovan HCT 71 Bosentan 71 Talabostat 71 Cardiotoxicity 71 Previously Treated 71 Saquinavir 71 Antitumor 71 Ranolazine 71 Zileuton 71 lapatinib Tykerb 71 serotonin norepinephrine reuptake inhibitor 71 Avanafil 71 Elotuzumab 71 MGd 71 Trastuzumab 71 liposomal formulation 71 Combination Therapy 71 Anti VEGF 71 Hormone Refractory Prostate Cancer 71 Hsp# Inhibitor 71 Mycophenolate Mofetil 71 Combination Treatment 71 vorinostat 71 visilizumab 71 Immunotherapeutic 71 Lamotrigine 71 Topiramate 71 Milnacipran 71 Vildagliptin 71 Files IND 71 pertuzumab 71 Rilonacept 71 Protease Inhibitor 71 Antiangiogenic 71 Ozarelix 70 BAL# [002] 70 Factor Xa inhibitor 70 Mitoxantrone 70 Efficacy Trial 70 Rigel R# 70 ritonavir boosted 70 Abatacept 70 mertansine 70 Antihypertensive 70 metaglidasen 70 Inhalation Solution 70 Varespladib 70 Zemplar 70 Initiates Enrollment 70 teriflunomide 70 Receives Orphan Drug Designation 70 Teriparatide 70 Initiates Clinical 70 Vandetanib 70 Apixaban 70 Etravirine 70 Acute Ischemic Stroke 70 Tolvaptan 70 Ezetimibe 70 Iloperidone 70 Gleevec resistant 70 Rheumatoid Arthritis Drug 70 PRT# 70 Adjuvant Chemotherapy 70 Long Term Efficacy 70 Completes Patient Enrollment 70 Well Tolerated 70 Allergic Rhinitis 70 Study Evaluating 70 Bucindolol 70 Novel Oral 70 Ustekinumab 70 Gemcitabine 70 Fenofibrate 70 immunosuppressant drug 70 novel oral anticoagulant 70 Intranasal 70 RNAi Therapeutic 70 Serdolect ® 70 Anticancer Agent 70 Initiates Clinical Trial 70 Phase 2b Study 70 MKC# MKC# PP 70 See CLINICAL PHARMACOLOGY 70 LY# [002] 70 Drug Shows Promise 70 Efficacious 70 Fingolimod 70 Fixed Dose 70 Elesclomol 70 Enzastaurin 70 Protease Inhibitors 70 Darusentan 70 Darunavir 70 Preclinical Data 70 Lanthanum Carbonate 70 HQK 70 Prilosec omeprazole 70 pegylated interferons 70 Pooled Analysis 70 Fidaxomicin 70 Entecavir 70 Adalimumab 70 Septic Shock 70 Inhalation Aerosol 70 receptor tyrosine kinase inhibitor 70 sodium glucose cotransporter 70 Sustiva efavirenz 70 Pivotal Phase III 70 troglitazone 70 amikacin 70 Parnate 70 Metastatic Melanoma 70 Valopicitabine 70 Ropinirole 70 meropenem 70 Tipranavir 70 Investigational Drug 70 targeting CD# 70 Psoriasis Drug 70 Phase III Trial 70 Factor Receptor 70 Panitumumab 70 Lung Cancer Drug 70 Elagolix 70 peripherally acting 70 Daclizumab 70 anti angiogenic agent 70 Interferon Gamma 70 Desvenlafaxine 70 Elvitegravir 70 Enzyme Replacement Therapy 70 Patient Enrollment 70 losartan Cozaar 70 laropiprant 70 Nebulized 70 fosbretabulin 70 Vaprisol 70 Dose Escalation 70 Inflammatory Markers 70 Demonstrates Significant 70 humanized monoclonal 70 Mylan Receives Approval 70 Novel Antibiotic 70 HMG CoA reductase inhibitors 70 ribavirin USP 70 Initiates Phase III 70 Diabetic Nephropathy 70 amifostine 70 omalizumab Xolair 70 selective agonist 70 selective antagonist 70 Orally administered 70 pharmacokinetic interactions 70 Azacitidine 70 Submits NDA 70 Bivalirudin 70 Renal Cell Carcinoma 70 GSK# [002] 70 Posaconazole 70 angiogenesis inhibitor 70 Tocilizumab 70 Anti Tumor Activity 70 Thiazolidinediones 70 Salmeterol 70 Telbivudine 70 bevacizumab Avastin 70 Initiate Phase 70 Tesamorelin 70 Sorafenib 70 Belimumab 70 Intelence 70 Darinaparsin 70 Fluvastatin 70 Unfractionated Heparin 69 Copegus ribavirin 69 xanthine oxidase inhibitor 69 Tesetaxel 69 Ziprasidone 69 Therapeutic Vaccine 69 prescribed proton pump 69 small molecule tyrosine 69 Liprotamase 69 Presents Preclinical 69 Sustained Release 69 leukotriene receptor antagonist 69 infliximab Remicade 69 Cyclooxygenase 2 69 Medoxomil 69 haloperidol Haldol 69 fenretinide 69 VEGF inhibitors 69 First Patient Dosed 69 Pivotal Study 69 Receives Approvable Letter 69 Ticagrelor 69 Natalizumab 69 Peginterferon alfa 2b 69 protein tyrosine phosphatase 1B 69 nilotinib Tasigna 69 Squalamine 69 Abacavir 69 NDA Submission 69 plasma kallikrein inhibitor 69 paricalcitol 69 Analgesic 69 Starlix 69 Ridaforolimus 69 Refractory Hodgkin Lymphoma 69 Peginterferon Alfa 2a 69 Doxorubicin 69 Interferon beta 1a 69 Eraxis 69 Cilostazol 69 Improves Survival 69 Omacetaxine 69 Ixabepilone 69 mycophenolate mofetil 69 sertraline Zoloft 69 RhuDex 69 5 HT6 receptor 69 Celebrex celecoxib 69 Vidofludimus 69 nucleotide analogue 69 Combo Therapy 69 Paraplatin ® 69 Glimepiride 69 metastatic malignant 69 Plasmin 69 Gout Drug 69 Heparins 69 Advanced Renal Cell 69 FDA Okays 69 MEVACOR 69 Kidney Transplant Patients 69 gefitinib Iressa 69 Naive Patients 69 Laquinimod 69 Autologous Stem Cell Transplantation 69 VAPRISOL 69 Naproxcinod 69 Recombinant Human 69 AZT zidovudine Retrovir 69 Didanosine 69 Azathioprine 69 oxaliplatin Eloxatin 69 Fungal Infections 69 pegylated liposomal doxorubicin 69 LAF# 69 basiliximab 69 Rotigotine 69 Lamivudine 69 Tigecycline 69 Angioedema 69 Occlusive Disease 69 Survival Benefit 69 Olaparib 69 Levofloxacin 69 Treated Patients 69 Cannabinoid 69 glatiramer 69 Immunogenic 69 abacavir Ziagen 69 ACE Inhibitor 69 HDAC Inhibitor 69 Aptivus ® 69 Chronic Myeloid Leukemia 69 Tekamlo 69 Onconase 69 Relapsing Multiple Sclerosis 69 tenofovir emtricitabine 69 CCX# 69 Platelet Inhibition 69 selective kinase inhibitor 69 ipratropium bromide 69 Everolimus 69 Systemic Delivery 69 nucleoside analog 69 ezetimibe Zetia 69 Severe Sepsis 69 vapreotide acetate 69 Dabigatran etexilate 69 IMiDs ® 69 Enoxaparin 69 Lupus Drug 69 CYT# potent vascular disrupting 69 tyrosine kinase inhibitor 69 diabetic neuropathic pain 69 Allogeneic 69 imatinib Gleevec 69 Fibrinogen 69 imatinib Gleevec ® 69 Dacogen decitabine 69 Doripenem 69 Fibrates 69 methylnaltrexone bromide 69 Phase IIb Clinical Trial 69 Mirapexin 69 Advanced Melanoma 69 Pegloticase 69 Initiates Phase II 69 Cancidas 69 Palifosfamide 69 Neulasta ® 69 paroxetine Paxil 69 factor Xa inhibitor 69 Hepatic Encephalopathy 69 ULORIC 69 Anidulafungin 69 tigecycline 69 Monopril 69 Pioglitazone 69 PEG SN# 69 sunitinib Sutent ® 69 Pregabalin 69 Renin Inhibitor 69 Voreloxin 69 Polymerase Inhibitor 69 Deforolimus 69 HuMax EGFr 69 BAY #-# 69 Hydrochlorothiazide 69 Aceon 69 Epivir 69 Treating Chronic 69 canakinumab 69 Linagliptin 69 Tumor Growth 69 ACTEMRA TM 69 STELARA TM 69 alefacept 69 reslizumab 69 Paliperidone Palmitate 69 Cinacalcet 69 PDE# 69 AEG# 69 Randomized Double blind 69 docetaxel Taxotere R 69 Nexavar ® 69 ZD# [001] 69 Aortic Stenosis 69 Tolerability 69 Improves Outcomes 69 HCQ 69 vidofludimus 69 Pharmacokinetic Study 69 TREDAPTIVE 69 Dalbavancin 69 Uric Acid 69 Nucleoside 68 Completes Enrollment 68 Venlafaxine 68 alpha blocker 68 Vimpat R 68 oral renin inhibitor 68 Decitabine 68 ALN HPN 68 Kuvan sapropterin dihydrochloride 68 intranasal formulation 68 Glufosfamide 68 ThermoDox R 68 Pegylated Liposomal Doxorubicin 68 FASLODEX 68 Antiviral Therapy 68 Exemestane 68 Adenoma Prevention 68 Radiofrequency Ablation RFA 68 orally administered inhibitor 68 CYT# QbG# 68 esophageal candidiasis 68 Imatinib 68 direct thrombin inhibitors 68 #I TM# 68 Eszopiclone 68 reuptake inhibitor 68 INCB# [001] 68 Placebo Controlled Trial 68 Roche Pegasys 68 Alemtuzumab 68 Lenocta 68 insulin sensitizing 68 Topotecan 68 eosinophilic asthma 68 IL# PE#QQR 68 Oral Spray 68 Demonstrated Significant 68 statin simvastatin 68 Cetuximab Erbitux 68 cetuximab Erbitux R 68 alpha 2a 68 PEGylated anti 68 Small Molecule 68 Prospective Randomized 68 Pivotal Phase 68 Thiovir 68 Genentech Rituxan 68 ergot derivatives 68 OMNARIS HFA 68 ENMD # 68 Anastrozole 68 Shows Efficacy 68 GAMMAGARD LIQUID 68 Antiplatelet 68 Renal Impairment 68 DU #b 68 Benign Prostatic Hyperplasia 68 Study Demonstrates 68 NAVISTAR R 68 PDE4 inhibitor 68 Diuretic 68 targeted radiotherapeutic 68 Novel Therapeutic 68 AstraZeneca Symbicort 68 leukotriene receptor antagonists 68 Epilepsy Drug 68 Disease Modifying 68 Incretin 68 Azedra 68 Infected Patients 68 Anti Angiogenic 68 ATACAND 68 Adjuvant Therapy 68 vascular disrupting agents 68 Gilead Viread 68 Metastatic Colorectal Cancer 68 II Clinical Trial 68 Tumor Response 68 uricase 68 levocetirizine 68 R Saizen R 68 beta 1a 68 boosted protease inhibitor 68 Mouse Model 68 proteasome inhibitors 68 Tofacitinib 68 Universal Flu Vaccine 68 Vernakalant 68 Prophylactic Treatment 68 TG# [003] 68 OMP #M# 68 Arcalyst 68 Clinical Outcome 68 Antipsychotic 68 Arranon 68 angiotensin converting enzyme inhibitors 68 Autoimmune Disease 68 Combination therapy 68 Torisel 68 NS#/#A protease 68 Gemzar gemcitabine 68 Immunomodulatory 68 baminercept 68 antifibrotic 68 SUTENT ® 68 RAPAFLO 68 Newly Diagnosed Multiple Myeloma 68 non nucleoside inhibitor 68 amprenavir 68 dasatinib Sprycel ® 68 drug zotarolimus 68 Orally Active 68 Pegylated 68 Adefovir 68 Patients Receiving 68 CYP#A# substrate 68 Angiotensin II 68 Oritavancin 68 Demonstrates Positive 68 multi kinase inhibitor 68 Lysteda 68 Bavituximab 68 Malignant Glioma 68 Biolimus A9 68 Aviptadil 68 Transdermal Delivery 68 FDA APPROVES 68 pravastatin Pravachol 68 azilsartan medoxomil 68 sitagliptin metformin 68 metformin HCl 68 Treatment Naïve 68 Novel Compound 68 PRN FDA Approves 68 Vascugel 68 Breast Cancer Cells 68 diclofenac Voltaren 68 Cytochrome P# 68 SPRYCEL ® 68 Interferon alpha 68 Expanded Indication 68 aspirin clopidogrel 68 Improved Survival 68 Dabigatran 68 SYN# 68 HoFH 68 Darapladib 68 Heart Failure Patients 68 Phase III Trials 68 Ganciclovir 68 Granulocyte Colony Stimulating Factor 68 irbesartan 68 mTOR inhibitor 68 Interferon beta 1b 68 beta blocker atenolol 68 Oral Anticoagulant 68 eltrombopag 68 lamotrigine Lamictal 68 invasive candidiasis 68 Ecallantide 68 Eluting Stent 68 Campath alemtuzumab 68 Xeloda ® 68 Sporanox 68 myopathy rhabdomyolysis 68 cidofovir 68 Cloretazine 68 induce orthostatic hypotension 68 elvitegravir 68 Cytarabine 68 DOXIL 68 PRTX 68 calcineurin inhibitors 68 Estrogen Receptor 68 Intravitreal 68 SERMs 68 Paxil paroxetine 68 itraconazole 68 Linaclotide 68 Ixempra 68 dual endothelin receptor antagonist 68 Adjunctive Therapy 68 Atacand 68 Seliciclib 68 Intravail ® 68 Atopic Dermatitis 68 Saxagliptin 68 aliskiren 68 histone deacetylase inhibitor 68 AVAPRO 68 Perforomist ™ Inhalation Solution 68 IV Busulfex 68 ST Elevation Myocardial 68 Rotavirus Vaccine 68 Drug Prevents 68 Ocrelizumab 68 echinocandin 68 Is Well Tolerated 68 rosiglitazone maleate 68 Levaquin levofloxacin 68 Humanized Anti 68 denileukin diftitox 68 panitumumab Vectibix 68 Launches Generic Version 68 Clinical Trial Evaluating 68 Panzem 68 acetonide FA 68 docetaxel Taxotere 68 trimethoprim sulfamethoxazole 68 Vfend 68 Glatiramer acetate 68 malignant ascites 68 Teva Provides Update 68 Randomized Phase 68 CTAP# Capsules 68 sorafenib tablets 68 Nexavar sorafenib 68 Generic Versions 68 Xanafide 68 atrasentan 68 Oral Insulin 68 Double Blind Randomized 68 isoproterenol 68 Progressive Multifocal Leukoencephalopathy 68 ACTOS ® 68 hyperphenylalaninemia HPA due 68 rFVIIa 68 refractory gout 68 inhibitor RG# 68 octreotide acetate 68 Camptosar ® 68 Significantly Improves 68 Bupropion 68 rituximab Rituxan 68 Bafetinib 68 Pivotal Trial 68 First Patient Enrolled 68 vildagliptin 68 DNA intercalator 68 Sprycel dasatinib 68 Metastatic Prostate Cancer 68 lucinactant 68 medoxomil 68 Thrombin 68 Roflumilast 68 Primary Hypercholesterolemia 68 Ramelteon 68 inhibitor PPI 68 IMA# 68 Antifungal 68 MTP inhibitor 68 uric acid lowering 68 salmeterol fluticasone 68 Present Preclinical Data 68 Fracture Risk 68 alkylating agent 68 rivastigmine Exelon 68 highly selective inhibitor 68 ReoPro 68 Loxapine 68 Tumor Targeting 68 Cytotoxic 68 selective inhibition 68 Alinia 68 Captopril 68 Carbamazepine 68 First Patient Treated 68 mesylate 68 terfenadine 68 Pirfenidone 68 JAK2 Inhibitor 68 Triglide 68 Hyperlipidemia 67 multikinase inhibitor 67 Gemzar ® 67 atazanavir sulfate 67 CA4P 67 renin inhibitor 67 Antiviral Activity 67 VA# [002] 67 Hepatocellular Carcinoma 67 Radioimmunotherapy 67 Sandostatin R 67 platelet inhibitor 67 valsartan Diovan 67 indinavir Crixivan 67 beta interferons 67 pimozide 67 nephrotoxicity 67 Vinorelbine 67 cetuximab Erbitux 67 bezafibrate 67 pioglitazone HCl 67 targeted antifolate 67 dexamethasone Decadron 67 Tekturna HCT 67 Gamunex C 67 Severe Asthma 67 Famotidine 67 flecainide 67 chimeric monoclonal antibody 67 bevacizumab Avastin ® 67 2 methoxyestradiol 67 Kepivance 67 opioid receptor antagonist 67 MEK Inhibitor 67 Nesiritide 67 Lixivaptan 67 JAK inhibitor 67 Filgrastim 67 Oral Formulation 67 virus HCV protease inhibitor 67 Bezielle 67 somatostatin analogue 67 pemetrexed Alimta 67 Nanoemulsion 67 nicardipine 67 Demonstrates Statistically Significant 67 Doxil 67 antidiabetic 67 Anacetrapib 67 Inhaled nitric oxide 67 Therapeutic Potential 67 5 fluorouracil leucovorin 67 Bayer Onyx 67 Vitro Activity 67 Cloretazine VNP#M 67 Antigen Specific 67 flavopiridol 67 Edarbi 67 mTOR mammalian target 67 IAP inhibitors 67 Hydrochlorothiazide Tablets 67 CYP#A# CYP#D# 67 Cymbalta duloxetine 67 administered concomitantly 67 protease inhibitors PIs 67 SCH # 67 FDA Accepts 67 Pimavanserin 67 Phase 2a Trial 67 selective A2A adenosine receptor 67 Antithrombin 67 IND Application 67 Combination REOLYSIN R 67 CD# monoclonal antibody 67 alfa 2a 67 orally dosed 67 Valproate 67 inhalation powder 67 Bacterial Vaginosis 67 relapsed MM 67 Pediatric Patients 67 Parathyroid Hormone 67 anti CD3 67 Sipuleucel T 67 Preclinical Models 67 oral Janus kinase 67 paclitaxel Taxol 67 Pramlintide 67 oral dual endothelin 67 orally disintegrating 67 Levoleucovorin 67 benazepril 67 Autoimmune Diseases 67 adult mesenchymal stem 67 Resten NG 67 Vorinostat 67 neuroprotectant 67 Retinoic Acid 67 prasugrel Effient 67 phase IIb trial 67 anti CD3 antibody 67 Antifungals 67 FUSILEV enhances 67 histone deacetylase HDAC inhibitor 67 Formoterol 67 Amplimexon 67 Infliximab 67 long acting muscarinic 67 Antibody Drug Conjugate 67 QVAR ® 67 cinacalcet 67 Revlimid lenalidomide 67 HCl Injection 67 Fabry Disease 67 glatiramer acetate 67 QVA# 67 BZA CE 67 clopidogrel Plavix 67 Ramoplanin 67 oral anticoagulant 67 Beta Blocker 67 midstage clinical 67 trastuzumab Herceptin 67 Treatment Naive Patients 67 Maleate 67 Vidaza R 67 Controlled Trial 67 Immunosuppression 67 Immunosuppressant 67 Amrubicin 67 leflunomide 67 hydroxychloroquine 67 ALGRX 67 Atomoxetine 67 Bevacizumab Avastin 67 olmesartan 67 Trabectedin 67 Epirubicin 67 Interferon Alpha 67 nucleoside analogues 67 Mycamine 67 Trodusquemine MSI 67 mu opioid receptor antagonist 67 Prostate Cancer Vaccine 67 vinorelbine tartrate 67 antiarrhythmic 67 APTIVUS 67 Archexin 67 Shows Promising 67 Sugammadex 67 radiation sensitizer 67 OMP #R# 67 abatacept Orencia 67 Humira adalimumab 67 Mucosal 67 OncoVex 67 tipranavir 67 Fenretinide 67 renal toxicity 67 CCX# B 67 Fludarabine 67 HCV NS5B polymerase 67 sunitinib malate 67 noscapine 67 Double Blind Placebo 67 CIMZIA TM 67 Allopurinol 67 Myelofibrosis 67 Schizophrenia Drug 67 aldosterone antagonists 67 Lupus Nephritis 67 Therapy Reduces 67 topiramate Topamax 67 clevidipine 67 Known generically 67 galiximab 67 canagliflozin 67 Delayed Release